News HOOKIPA Pharma Inc.

Equities

HOOK

US43906K1007

Real-time Estimate Cboe BZX Other stock markets 03:54:55 2024-06-10 pm EDT			5-day change	1st Jan Change
0.795 ^USD	-2.93%		-9.67%	-3.09%

Jun. 05	HC Wainwright Adjusts Price Target on HOOKIPA Pharma to $6 From $5, Maintains Buy Rating	MT
Jun. 04	Transcript : HOOKIPA Pharma Inc. - Special Call

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Price Target on HOOKIPA Pharma to $6 From $5, Maintains Buy Rating	Jun. 05	MT
Transcript : HOOKIPA Pharma Inc. - Special Call	Jun. 04
HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting	Jun. 04	GL
HOOKIPA Pharma Inc Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting	Jun. 04	CI
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting	May. 30	GL
HOOKIPA Pharma Inc. Announces Positive Clinical Data to Be Presented At the American Society for Clinical Oncology 2024 Annual Meeting	May. 23	CI
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting	May. 23	GL
HOOKIPA Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights	May. 09	GL
Transcript : HOOKIPA Pharma Inc. - Special Call	Apr. 25
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab	Apr. 25	GL
HOOKIPA Pharma Inc. Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab	Apr. 25	CI
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers	Apr. 24	GL
HOOKIPA Pharma Inc. Announces FDA Clearance of Its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers	Apr. 24	CI
HOOKIPA Pharma Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(4)	Apr. 17	AQ
HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)	Apr. 16	GL
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration	Apr. 10	GL
HOOKIPA Pharma Inc. Announces European Medicines Agency Grant Prime Designation for the Investigational Product HB-200	Apr. 10	CI
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	Mar. 25	AQ
HOOKIPA Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News HOOKIPA Pharma Inc.

Equities

HOOK

US43906K1007

Summary

Filters